作者: Agnès Laplanche , Isabelle Monnet , Juan Antonio Santos-Miranda , Etienne Bardet , Cécile Le Péchoux
DOI: 10.1016/S0169-5002(98)00056-7
关键词:
摘要: We conducted a randomised clinical trial on 211 patients with small-cell lung cancer in complete remission (CR). The aim of this was to evaluate the effect prophylactic cranial irradiation (PCI) overall survival. Eligible were randomly assigned receive either PCI (100 patients) or no (111 patients). Each centre allowed use its own protocol as long total dose within range 24-30 Gy and delivered less than 3 weeks fractions less. mean follow-up is 5 years. survival curves do not differ significantly (P = 0.25) between two groups. 4-year rate (95% confidence interval) 22% [15-32%] group versus 16% [10-25%] control group. relative risk death compared 0.84 CI [0.62-1.13]). incidence brain metastasis lower group, but difference statistically significant 0.14). cumulative 44% [32-57%] 51% [38-63%] In conclusion, study, which had be closed prematurely, found terms metastases nor